Where Protocols Fall Short, Patient-Centered Education Can Help Bridge the Gap
Survival outcomes across several hematologic cancers have vastly improved in recent years, bolstered by advances in genomic profiling, cellular therapies like CAR-T and bispecific antibodies.
But with innovation comes the creation of ambiguity during real-time clinical decisions. Clinical trial results outpace guideline updates, and the diversity of disease subtypes in heme-onc makes having a single approach impossible. Providers must rely on peer insights to deliver optimal care.
“There is an important need for clinicians to have information about latest advances in oncology care in a rapid, concise, and easy to understand format that is delivered by a trusted source.”
– Susan T. Vadaparampil, PhD MPH
Associate Center Director for Community Outreach & Engagement
Professor, Department of Health Outcomes and Behavior
Moffitt Cancer Center
At Medlive, we respond to evidence shifts by designing digital education that helps clinicians apply emerging data where it matters most – during real-time clinical decisions. Our scenario-driven modules, KOL-led insights, and interactive decision pathways don’t just teach the ‘what’. They address the ‘now what’ ensuring hematologists are prepared to lead care innovation, not just react to it.
“There is no one-size-fits-all approach across hematologic malignancies. Our role is to help providers navigate the nuances through timely, scenario-based education – facilitating a patient-centered approach.”
— Tariqa Ackbarali, PhD, MS, CHCP
Vice President, Medical Oncology, Medlive
If you’re heading to ASCO, come to booth #34070 to see how we’re building education that moves as fast as science—or check out our latest real-world case discussions, emerging data updates, and peer insights at www.medlive.com/cancer any time.
